WebCYT Complete Cyteir Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... or $75.25 per share, and will hold a 1.5 billion ... WebCyteir Therapeutics, Inc. (CYT) Stock Price, News, Quote & History - Yahoo Finance Dow 30 (-0.33%) Russell 2000 (+0.50%) Cyteir Therapeutics, Inc. (CYT) NasdaqGS - … NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend … Discover historical prices for CYT stock on Yahoo Finance. View daily, weekly or … Find out all the key statistics for Cyteir Therapeutics, Inc. (CYT), including … Get the detailed quarterly/annual income statement for Cyteir Therapeutics, Inc. … View the basic CYT option chain and compare options of Cyteir Therapeutics, … Find out the direct holders, institutional holders and mutual fund holders for … Find the latest Cyteir Therapeutics, Inc. (CYT) stock discussion in Yahoo … See Cyteir Therapeutics, Inc. (CYT) stock analyst estimates, including earnings … See Cyteir Therapeutics, Inc. (CYT) Environment, Social and Governance … LEXINGTON, Mass., February 06, 2024--Cyteir Therapeutics, Inc. ("Cyteir") …
Cyteir Therapeutics, Inc. Stock Forecast & Price Target (Analyst ...
WebApr 10, 2024 · Cyteir Therapeutics (CYT) has a Smart Score of 3 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... (CYT) Stock Price & Analysis. Follow. 27 Followers. Portfolio. CYT Stock Chart & Stats. Advanced Chart > ... The company reported -$0.25 earnings per share for the … WebMar 30, 2024 · Share Statistics. CYT has 35.65 million shares outstanding. The number of shares has increased by 80.89% in one year. Shares Outstanding 35.65M: Shares Change (YoY) ... The average price target for CYT is $2.38, which is 31.49% higher than the current price. The consensus rating is "Sell". Price Target $2.38: dunk red card
CYT: Cyteir Therapeutics Inc Stock Price Quote - NASDAQ GS
WebCYT-108 Development is De-Risked. Cytonics has already successfully commercialized a therapy for osteoarthritis.This FDA-approved medical device (the Autologous Protease Inhibitor Concentrate therapy, or “APIC”) leverages the cartilage-protecting properties of a naturally occurring blood protein, called alpha-2-macroglobulin (A2M), by purifying the … WebJan 18, 2010 · CYT Share Price: $0.130 Day High: $0.000: Day Low: $0.000: Last Close: $0.130: CYT Share Price Movement - ( No change ) Prices as at 16:10, 18 Jan 2010 + Security prices are delayed by at least 20 minutes and are indicative only. CYT Related Research. CYT Directors. Name Position Start Date ... WebApr 11, 2024 · A high-level overview of Cyteir Therapeutics, Inc. (CYT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. dunk refreshers